Genetic Testing (PGT/PGD) in Assam: A Complete Clinical Guide for Couples Seeking Healthy Pregnancies

Preimplantation Genetic Testing (PGT) is an umbrella term for several techniques used to evaluate embryos created through IVF before they are transferred to the uterus. There are three main subtypes: PGT-A (Aneuploidies), which screens for extra or missing chromosomes; PGT-M (Monogenic disorders), used when one or both parents carry a known single-gene mutation; and PGT-SR (Structural Rearrangements), used when a parent carries a chromosomal translocation or inversion.

Preimplantation Genetic Diagnosis (PGD) is technically the older term that now largely corresponds to PGT-M — it refers to testing embryos specifically for a known hereditary disease in the family. For example, a couple in Guwahati where both partners are carriers of beta-thalassaemia (a condition with notably high carrier rates in Assam's Bodo and Bengali communities) would use PGD/PGT-M to ensure only unaffected embryos are transferred.

Understanding which type of genetic testing applies to your situation requires a thorough genetic counselling session — something the HomeIVF Medical Board ensures every patient receives before proceeding. The right test depends on your age, reproductive history, and any known family genetic conditions.

Assam has a unique genetic health profile that makes PGT and PGD especially significant for local families. Beta-thalassaemia carrier rates are notably elevated among several communities in the Brahmaputra valley and hill districts. Sickle cell disease, spinal muscular atrophy (SMA), and certain autosomal recessive disorders have documented clusters in specific ethnic groups across the state.

Beyond hereditary conditions, Assam's fertility landscape is also affected by factors that increase chromosomal risk: a rising average maternal age at first pregnancy, high rates of consanguineous marriages in certain communities, and documented environmental exposures — including pesticide use in agricultural districts like Nagaon and Golaghat — that may influence reproductive health.

Furthermore, limited local access to comprehensive genetic counselling means many Assam couples have never been informed they are at risk. Couples who have experienced two or more miscarriages, or who have delivered a child with a chromosomal condition, are often the most underserved. HomeIVF's tele-genetic counselling model allows families in Dibrugarh or Silchar to receive the same evidence-based guidance as patients in major metros, without the burden of travel and repeated clinic visits.

Not every IVF cycle requires genetic testing, but there are clear clinical indications where the HomeIVF Medical Board strongly recommends evaluation. Women above 37 years of age have a statistically higher risk of producing aneuploid embryos, making PGT-A a valuable adjunct to standard IVF. Couples with a history of two or more consecutive miscarriages — a presentation seen frequently in fertility clinics in Guwahati — should be evaluated for chromosomal translocations in either partner before proceeding.

Families with a previous child affected by a chromosomal disorder (such as Down syndrome, Edwards syndrome, or Patau syndrome) or a known genetic disease (such as haemophilia, Duchenne muscular dystrophy, or thalassaemia) are prime candidates for PGT-M/PGD. Similarly, couples who have experienced repeated IVF failure — defined as three or more failed embryo transfers — may benefit from PGT-A to ensure only euploid (chromosomally normal) embryos are selected.

Male factor infertility with severe oligospermia or azoospermia can also be associated with higher rates of sperm chromosomal abnormalities, increasing the rationale for embryo-level screening. If you or your partner fall into any of these categories and are based in Jorhat, Tezpur, or elsewhere in Assam, a consultation with HomeIVF can help determine the right testing pathway for your specific situation.

The journey through genetic testing within an IVF cycle follows a clear, structured pathway when managed through HomeIVF. It begins with a comprehensive initial consultation — available via video or at a HomeIVF-partnered facility in Guwahati — where your reproductive history, family genetic history, and any previous test results are reviewed by the HomeIVF Medical Board.

If PGT or PGD is recommended, a personalised ovarian stimulation protocol is designed and monitoring begins. HomeIVF's home-monitoring service allows patients in Silchar or Dibrugarh to have hormone blood draws performed at home by certified phlebotomists, with results reviewed remotely by senior embryologists and fertility specialists. This eliminates the need for repeated clinic visits during the stimulation phase.

Egg retrieval and fertilisation occur at a HomeIVF-partnered certified IVF laboratory. Embryos are cultured to the blastocyst stage (Day 5 or 6), at which point a few cells are carefully biopsied from the trophectoderm (the outer layer) without harming the inner cell mass that will become the baby. Biopsied cells are sent to a NABL-accredited genetics laboratory for Next-Generation Sequencing (NGS) analysis — the current gold standard. Embryos are vitrified (frozen) while awaiting results. Once euploid or unaffected embryos are identified, a frozen embryo transfer (FET) is planned in a subsequent cycle.

Before proceeding to embryo-level genetic testing, both partners typically undergo a baseline genetic workup. This includes karyotyping — a test that maps the chromosomes of each partner to detect translocations, inversions, or numerical abnormalities. Carrier screening panels are also recommended, especially for communities in Assam with documented elevated carrier frequencies for thalassaemia and haemoglobinopathies.

For PGT-M (single-gene disorder testing), a probe or test specific to the family's mutation must be designed — a process called workup or validation, which takes approximately 4–8 weeks before an IVF cycle can begin. This requires DNA samples from the couple and, when available, an affected family member. The HomeIVF Medical Board coordinates this with accredited genetics partners across India to ensure Assam-based families are not disadvantaged by geography.

For embryos, Next-Generation Sequencing (NGS) is the preferred platform for PGT-A, offering full 24-chromosome analysis. Array Comparative Genomic Hybridisation (aCGH) may be used in specific centres. The biopsy is performed by a trained embryologist under a microscope, with laser-assisted hatching facilitating precise cell removal. HomeIVF ensures all partner laboratories meet international quality benchmarks — a critical assurance for patients in Guwahati or Tezpur who cannot physically inspect a facility.

A standard IVF cycle with PGT-A in India takes approximately 8–12 weeks from the start of stimulation to embryo transfer, with additional time if PGT-M probe design is required. For Assam-based patients, the HomeIVF model is structured to minimise the number of in-person visits required, with most monitoring done remotely and egg retrieval scheduled at a convenient partnered centre in Guwahati.

HomeIVF IVF packages start from ₹1.5 lakh, with genetic testing components (PGT-A, PGT-M, or PGT-SR) discussed transparently during the initial consultation based on clinical need. No patient should proceed with genetic testing without understanding the full scope, rationale, and realistic expectations — and the HomeIVF Medical Board ensures this informed consent process is thorough and unhurried.

IVF success rates in India typically range from 40–55% per cycle depending on age and cause. When PGT-A is used to select euploid embryos, cumulative success rates per transfer are generally higher, though the number of available transferable embryos may be lower after screening. For women under 35 with normal ovarian reserve, PGT-A may not always be necessary — the HomeIVF Medical Board provides individualised guidance rather than a one-size-fits-all recommendation.

Despite the clinical need, several barriers have historically prevented Assam couples from accessing PGT and PGD. The most significant is geography: the Northeast's limited super-speciality fertility infrastructure means that advanced embryology services are concentrated in a handful of clinics in Guwahati, with very little available in Dibrugarh, Silchar, Jorhat, or smaller towns. Patients from hill districts face even greater challenges.

Financial opacity is another barrier — many patients in Assam have reported being quoted widely varying prices without clear explanation of what is and is not included. HomeIVF addresses this with structured, transparent package consultations where every component is explained before commitment.

Language and cultural barriers also matter. HomeIVF offers consultations in Assamese and Bengali alongside English and Hindi, ensuring that couples from diverse linguistic backgrounds across the state feel heard and understood. Stigma around genetic testing — some families fear the implications of discovering a hereditary condition — is addressed through compassionate, non-directive counselling by the HomeIVF Medical Board.

Finally, the absence of trusted post-testing follow-up support has deterred couples from proceeding. HomeIVF's continuity-of-care model means the same team that guided a couple in Tezpur through their genetic workup also manages their embryo transfer cycle, reducing handoff errors and emotional distress.

Genetic testing in the context of fertility treatment is not purely a laboratory exercise — it carries profound emotional weight. Discovering that a significant proportion of your embryos are chromosomally abnormal, or that both you and your partner carry a serious hereditary mutation, can be deeply distressing. Couples in Assam face these challenges with the added pressure of limited local mental health support specifically tailored to fertility-related grief and anxiety.

HomeIVF integrates emotional and psychological support at every stage of the PGT/PGD journey. Before testing, genetic counsellors help couples understand what various possible results would mean and how they would affect treatment decisions. After results are received, counsellors are available to help process outcomes — whether the news is reassuring or difficult.

For couples in Guwahati or Silchar who have experienced repeated pregnancy losses and are now pursuing genetic testing for the first time, HomeIVF's support framework acknowledges that fertility treatment is a human experience, not merely a medical protocol. Peer support groups, available virtually for Assam patients, connect couples with others who have navigated similar journeys. The HomeIVF Medical Board's philosophy is that informed, emotionally supported patients make better treatment decisions and experience less burnout — ultimately leading to better outcomes.